For patients awaiting stoma reversal surgery, there is good news.

Published Date: 26 Apr 2023

According to new research, patients can rest assured that postponing stoma reversal surgery has no impact on long-term results.

Read Full News

Latest News

US Health Agency Moves to Increase Oversight Of Food Additives

The U.S. Food and Drug Administration on Monday took steps to increase oversight of food additives as part ⁠of the Trump administration's "Make America Healthy Again"...

Diffuse Axial Pain Linked to Peripheral Arthritis

The anatomical pattern of inflammatory back pain at disease onset may reveal which patients face a heightened risk for joint complications years later.

Acupuncture for IBS: Does It Really Help?

Acupuncture was tied to higher response rate, lower symptom severity, and better quality of life in IBS treatment, but doubts about reproducible efficacy remain.

TACE Plus Ablation Boosts Overall Survival in Liver Cancer

Combining transarterial chemoembolization with subsequent thermal ablation more than doubled PFS and overall survival in patients with liver-confined hepatocellular carcinoma ineligible for curative treatment.

Acting US FDA Chief Urges Confidence in Lettuce as Agency Updates Produce Safety Guidance

Acting U.S. FDA Commissioner Kyle Diamantas said on Tuesday Americans should feel confident in eating fresh produce, as the agency has finalized guidance for proper...

Somalia Malnutrition Response Hit by More Than 80% Funding Drop as Child Hunger Surges, MSF Says

Funding to tackle acute malnutrition in parts of Somalia has dropped by more than 80% this year, Médecins Sans Frontières said on Tuesday, even though one in every four...

Todays Updates

Freeman’s Lobotomy to Deep Brain Stimulation: What Changed?

The history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.

Wide Variation Seen in Lung Screening False-Positive Rates

US radiologists vary substantially in their reading of low-dose CT lung cancer screens, highlighting a need for measures to help standardize interpretation.

AVD Chemo Regimen Shows Promise in Older Patients With HL

Researchers compare first-line chemotherapy regimens in older patients with classical Hodgkin lymphoma to assess whether AVD is associated with better outcomes in routine care.

Do High-Risk Features of Prostate Cancer Boost HT Benefit?

Researchers analyze individual patient data from five randomized phase 3 trials comparing PORT alone vs PORT plus hormone therapy in patients with recurrent prostate cancer.

How Low Does PSA Need to Go in Metastatic Prostate Cancer?

A new real-world analysis helps clarify the most informative prognostic PSA benchmark in men with metastatic castration-sensitive prostate cancer.

Tissue-Free ctDNA Strongly Prognostic of Recurrence in TNBC

Tissue-free ctDNA may be comparable to tumor-informed assays in detecting molecular residual disease.

Todays Updates

Freeman’s Lobotomy to Deep Brain Stimulation: What Changed?

The history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.

Wide Variation Seen in Lung Screening False-Positive Rates

US radiologists vary substantially in their reading of low-dose CT lung cancer screens, highlighting a need for measures to help standardize interpretation.

AVD Chemo Regimen Shows Promise in Older Patients With HL

Researchers compare first-line chemotherapy regimens in older patients with classical Hodgkin lymphoma to assess whether AVD is associated with better outcomes in routine care.

Do High-Risk Features of Prostate Cancer Boost HT Benefit?

Researchers analyze individual patient data from five randomized phase 3 trials comparing PORT alone vs PORT plus hormone therapy in patients with recurrent prostate cancer.

How Low Does PSA Need to Go in Metastatic Prostate Cancer?

A new real-world analysis helps clarify the most informative prognostic PSA benchmark in men with metastatic castration-sensitive prostate cancer.

Tissue-Free ctDNA Strongly Prognostic of Recurrence in TNBC

Tissue-free ctDNA may be comparable to tumor-informed assays in detecting molecular residual disease.

Latest News

The U.S. Food and Drug Administration on Monday took steps to increase oversight of food additives as part ⁠of the Trump administration's "Make America Healthy Again"...

The anatomical pattern of inflammatory back pain at disease onset may reveal which patients face a heightened risk for joint complications years later.

Acupuncture was tied to higher response rate, lower symptom severity, and better quality of life in IBS treatment, but doubts about reproducible efficacy remain.

Combining transarterial chemoembolization with subsequent thermal ablation more than doubled PFS and overall survival in patients with liver-confined hepatocellular carcinoma ineligible for curative treatment.

Acting U.S. FDA Commissioner Kyle Diamantas said on Tuesday Americans should feel confident in eating fresh produce, as the agency has finalized guidance for proper...

Funding to tackle acute malnutrition in parts of Somalia has dropped by more than 80% this year, Médecins Sans Frontières said on Tuesday, even though one in every four...

News All Time

Etrasimod Effective As First-Line Advanced UC Therapy

Etrasimod can be an effective and safe first-line advanced therapy option in patients with ulcerative colitis who escalate after conventional treatment failure.

Does Doublet Chemotherapy Improve Survival in Rectal Cancer?

Patients with high-risk locally advanced rectal cancer were randomly assigned to receive doublet-LC TNT or conventional neoadjuvant chemoradiotherapy.

Radiation Boost Linked to Better Survival in Rectal Cancer

A phase 2 trial finds that adding a modest radiation boost improves 9-year survival without increasing toxicity, despite no improvement in pathologic complete response.

Creatinine Assay Bias Affects MELD Scoring

Bilirubin interference in commonly used creatinine assays artificially inflates MELD scores in liver transplant candidates, a study reports.

EHR Marker May Help Curb Risk for Liver Transplant Rejection

A remote intervention aimed at improving medication adherence may reduce organ rejection in liver transplant recipients at high risk.

Altimmune Drug Cuts Heavy Drinking in Mid-stage Trial for Alcohol Use Disorder

Altimmune said on Tuesday its experimental drug helped patients with alcohol use disorder cut back on heavy drinking ⁠in a mid-stage trial, sending the company's shares 10%...

Newer Antibiotics Show No Clear Benefit for Staph Infections

A new meta-analysis finds ceftaroline and ceftobiprole monotherapy show no clear advantage over standard therapy for non-urinary Staphylococcus aureus infections.

FDA Approves Freenome's Blood Test for Colorectal Cancer Screening

The U.S. FDA has approved Freenome's blood-based colorectal cancer screening test for older adults, paving the way ⁠for partner Abbott to launch it in the U.S. this fall,...

Company At Center Of US Cyclospora Outbreak Complained to White House, Source Says

U.S. produce supplier Taylor Farms complained to White House and Food and Drug Administration officials about the government's inspection process earlier this month, a...

Poultry Firm Recalls Nearly 1.6 Million Dozen Eggs Over Salmonella Risk, FDA Says

The U.S. FDA said on Wednesday that Midwest Poultry Services is recalling nearly 1.6 ⁠million dozen eggs produced in Texas due to potential Salmonella...

CRC Screening in Adults Under 50: Research Reveals Trends

After colorectal cancer screening guidelines were updated in 2021 to lower the screening age to 45, three studies look at how providers are reaching those patients.

Simple Risk Score Is the Best at Detecting Liver Fibrosis

The LiverRisk score outperformed the fibrosis-4 index for detecting moderate or greater fibrosis across all age groups, particularly in younger adults.

How to Predict Iron Therapy Response in IBD

Hepcidin and ferritin-based indices help identify patients with active inflammatory bowel disease who are less likely to respond to iron therapy.

‘A Tiny Blueberry’: How Ingestible Sensors Keep Shrinking

A new thermometer is powerful, accurate, and easily swallowed even by children. Inside the push to make the perfectly sized, perfectly powered ingestible device.

Anxiety May Undermine Treatment Response in Some GERD Cases

Higher anxiety is linked to poorer response to proton pump inhibitor treatment among patients with gastroesophageal reflux disease.

Older Adults Have Worse Lower GI Bleeding Outcomes

Older adults with lower gastrointestinal bleeding present with more severe disease and substantially higher 30-day mortality—yet most deaths stem not from bleeding itself, but from decompensation of underlying chronic conditions.

Recommended News For You

Adult overdose deaths on the rise

EMA Backs Breast Cancer SERD After FDA No Vote

Researchers discuss HER2-low and HER2-zero in breast cancer

An Eye Surgeon's Unexpected Discovery of the "Before and After".

ALK-positive lung cancer trial results show unprecedented progression-free survival.

Coupling dye and fiducial marking can improve precision in pulmonary nodule surgical resection

New imaging probe helps track prostate cancer and possibly treat it before resistance develops

Recommended Articles For You

Clinical Guidelines for Tumor Evolution Tracking Using Dynamic Molecular Profiling 

Unlocking The Power Of Cangrelor To Treat Heart Disease 

The Predictive Power of Targeted Radionuclide Therapy in Advanced Breast Cancer 

Introduction To Immune Thrombocytopenic Purpura 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Less Mental Decline With Darolutamide vs Enzalutamide in PC

2.

Asymptomatic Brain Metastases in EGFR-Mutant NSCLC

3.

MRI-Guided TULSA Speeds Recovery vs Robotic Prostatectomy

4.

Breast cancer-related fatigue: The benefits of adapted physical activity

5.

Except for Black Patients, the Rates of Gallbladder Cancer Are Stable or Declining.

1.

Beyond the Tumor: Emerging Frontiers in Cancer Systems Biology

2.

Unraveling the Mystery of Non-Caseating Granulomas: A Comprehensive Guide

3.

Tumor Microenvironment Readiness as a Predictor of Cancer Progression

4.

Esophageal Cancer Survival Rates and Outcomes: Evidence-Based Insights from Oncology Studies

5.

What Is A High MCV Level? Causes, Symptoms, And Treatment Options

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

1.

Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients

2.

Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment

3.

A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC

4.

Navigating the Complexities of Ph Negative ALL - Part IX

5.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot